Zantac has been around for decades. It is a well known drug to help treat stomach acid. What was not well known was that it could cause cancer. In 2019, new studies found that Zantac which uses the drug ranitidine produces a chemical called N-Nitrosodimethylamine (NDMA). NDMA is a known carcinogen. The FDA has set the acceptable daily intake limit for NDMA at 0.096 micrograms or 0.32 ppm for ranitidine. However, Zantac has been tested showing levels as high as 2.38 micrograms. This is a gross deviation from the allowable amount. Many individuals have developed stomach, liver, bile duct, pancreatic, colorectal or other forms of cancer and have been longtime users of Zantac or other over the counter rantidine drugs. Researchers, doctors, and now lawyers are working to connect the dots and pursue lawsuits against the makers of Zantac and other similar drugs for causing those cancers. If you or a loved one has been diagnosed with cancer and were a user of Zantac or other ranitidine drugs, please contact me today to discuss your rights. Please note that this article is attorney advertising.
Zantac may cause cancer
by Nicholas James Shemik on Feb. 07, 2020
Summary
Zantac, a well known, drug to treat stomach acid was recalled last year by its manufacturers over concerns that it may cause cancer. A bi-product of the drug is a chemical called N-Nitrosodimethylamine (NDMA). NDMA is a known carcinogen. In fact, it is a drug used to induce tumors in animals for scientific experiments. It has no business being in the human body. The FDA has a limit of the amount of NDMA consumable per day in the human body and Zantac grossly exceeds this limit. If you or a loved one has been diagnosed with cancer after using Zantac, please consult with an experienced attorney to discuss your rights.
